Front Page  |  China  |  India  |  Japan  |  Korea  |  Other Asia News  |  Other Emerging Markets  |  Features

---

Daiichi Sankyo New R&D Head Puts Emphasis On Faster Decision-making / Daiichi Sankyo has four large Phase III milestones in the next two years, followed by prioritization for early stage programs / PharmAsia News May 18, 2012 4:49 PM GMT

Catch’em Young! India Launches Screening Drive For Juvenile Diabetes / With 1 million children having type 1 diabetes, India gets into grassroots investigations. / PharmAsia News May 18, 2012 4:14 PM GMT

Pfizer’s Biosimilar Program: A MAB Dash After Biocon Deal Ends / Following the breakup in March of its insulin biosimilars deal with Biocon, Pfizer confirms plans to develop monoclonal antibody biosimilars on its own, and has put its first candidate, rituximab, into Phase 1 testing. / PharmAsia News May 18, 2012 4:13 PM GMT

BMS Dives Deeper Into China With First Discovery Partnership; Company Will Double R&D / BMS doubling down in China with discovery deal with Beijing’s Tsinghua University and plans to ramp up in diabetes and hepatitis. / PharmAsia News May 17, 2012 6:30 PM GMT

Roche’s Herceptin Is A Success Story In Brazil, And The Courts Play A Role / Roche has captured more than a third of Brazil's $611 million breast cancer market with Herceptin alone. / PharmAsia News May 17, 2012 4:29 PM GMT

Korea’s CJ CheilJedang To Launch Viagra Generics While Awaiting Patent Ruling / CJ will proceed with the sales launch despite Pfizer’s stance that Viagra's use-patent is valid and enforceable until May 2014. / PharmAsia News May 17, 2012 3:02 PM GMT

BIO Senior VP On International Affairs Joseph Damond On Removing Trade Barriers In Asia: An Interview With PharmAsia News (Part 2 of 2) / The former Pfizer and PhRMA exec talks about building the proper regulatory climate in emerging markets to foster innovation. / PharmAsia News May 16, 2012 5:15 PM GMT

China SFDA Vows Quick Action To Prevent Gel-Capsule Scandal Repeat / China’s State FDA spread the word to local authorities to respond quickly and harshly to any reports of unsafe gel capsules found in their areas as part of a long-term monitoring system to prevent a scandal repeat. / PharmAsia News May 18, 2012 5:01 PM GMT

China Party Official Vows Severe Response To Drug Kickbacks, Bribes / A Communist Party of China official vowed severe punishment for any hospital official or physician found to have taken kickbacks or charged extra fees involving drugs or medical devices in the nation’s health system, primarily at hospitals. / PharmAsia News May 18, 2012 5:00 PM GMT

Hikma Of Jordan Reports U.S. FDA Warning Letter Over N.J. Generics Plant / Jordan-based Hikma Pharmaceuticals, the Middle East’s largest drug maker, said it has received a warning letter from U.S. FDA about its production plant that could prove costly in the coming months for its generics business. / PharmAsia News May 18, 2012 4:58 PM GMT

Study Shows Aussie Coverage Of Another 3 Million For Statins Worthwhile / A joint Australia-British review estimated covering statins under national health plans at a cost of $196 million a year would be worth expanding coverage to as many as 3 million additional Australians. / PharmAsia News May 18, 2012 4:56 PM GMT

Japan’s Nihon Chouzai To Spend $126 Million To Expand Generics Plant / Nihon Chouzai, a maker of generic drugs as well as operator of dispensing pharmacies in Japan, says it will invest $126 million in the production end of its business over the next three years. / PharmAsia News May 18, 2012 4:54 PM GMT

Japan To Add Cervical Cancer, Two Meningitis Shots To Children’s Routine / Japan’s Ministry of Health, Labour and Welfare decided to add shots against cervical cancer and two causes of bacterial meningitis to the nation’s routine vaccination program for children. / PharmAsia News May 18, 2012 4:52 PM GMT

South Korea Reports 122,000 Medical Tourists In 2011, For 49% Increase / South Korea’s Health Ministry says the nation’s medical tourism business increased by nearly half in the number of foreign patients seeking treatment. / PharmAsia News May 17, 2012 11:00 AM GMT

J&J Targets China Manufacturers Of Psychiatric, Cancer Drugs For Buys / Johnson & Johnson is on the prowl for acquisitions of Chinese drug manufacturers with treatments for mental diseases, cancer and other treatments. / PharmAsia News May 17, 2012 11:00 AM GMT

Myanmar Democracy Leads To Quadrupled Health-Care Budget / Myanmar’s swift transformation to democracy could lead to an equal transformation of the nation’s health system, labeled the second worst in the world in 2000. / PharmAsia News May 17, 2012 11:00 AM GMT

Takeda M&A Head Says More Ties In Works To Replace Expired Drugs / Takeda Pharmaceuticals, smarting from a disappointing earnings report, could still seek more mergers and acquisitions in what it considers good fits for its current business. / PharmAsia News May 17, 2012 11:00 AM GMT